ExThera Medical is a leading brand that specializes in the development and commercialization of extracorporeal blood filtration devices. Their innovative products, such as the Seraph® 100 and OncoBind™ Blood Filters, are designed to remove a wide range of harmful substances from the bloodstream of patients. These devices have proven to be life-saving in critically ill patients with severe infections and have the potential to treat stage 4 metastatic cancer patients.

With a strong focus on addressing antimicrobial resistance, ExThera Medical has emerged as a key player in the healthcare industry. They have participated in the DARPA dialysis-like therapeutics program and have garnered positive results from independent clinical studies. Additionally, their products have been successfully used in the US and EU for the treatment of bloodstream infections.

Led by a team of experienced professionals, including the founder who developed this groundbreaking hemoadsorption technology, ExThera Medical is dedicated to serving healthcare professionals and patients alike. Their commitment to innovation and evidence-based medicine makes them a trusted choice in the field of extracorporeal blood filtration